The calcium and vitamin D controversy

Therapeutic Advances in Musculoskeletal Disease

Volumn 9, Issue 5, 2017, Pages 107-114

  Abrahamsen, Bo ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

calcium; cardiovascular risk; clinical trials; nutrition; osteoporosis; vitamin D

Indexed keywords

ARGIPRESSIN; CALCIUM; CALCIUM SENSING RECEPTOR; PARATHYROID HORMONE; VITAMIN D;

BONE DENSITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONFUSION; FEMALE; FRACTURE; HEART INFARCTION; HUMAN; MALE; MORTALITY; NEPHROLITHIASIS; OSTEOPOROSIS; PREVALENCE; PRIORITY JOURNAL; REVASCULARIZATION; REVIEW;

EID: 85018746741     PISSN: 1759720X     EISSN: 17597218     Source Type: Journal    
DOI: 10.1177/1759720X16685547     Document Type: Review

References (35)

1. Bolland MJ, Grey A, Reid IR., Vitamin D and falls. Time for a moratorium on vitamin D meta-analyses? BMJ 2009; 339: b4394.
2. Kostenuik P., On the evolution and contemporary roles of bone remodeling. 4th ed. Elsevier, 2013.
3. Hannan FM, Thakker RV., Calcium-sensing receptor (CaSR) mutations and disorders of calcium, electrolyte and water metabolism. Best Pract Res Clin Endocrinol Metab 2013; 27: 359–371.
4. Christakos S., Mechanism of action of 1,25-dihydroxyvitamin D3 on intestinal calcium absorption. Rev Endocr Metab Disord 2012; 13: 39–44.
5. Hanzlik RP, Fowler SC, Fisher DH., Relative bioavailability of calcium from calcium formate, calcium citrate, and calcium carbonate. J Pharmacol Exp Ther 2005; 313: 1217–1222.
6. Martini L, Wood RJ., Relative bioavailability of calcium-rich dietary sources in the elderly. Am J Clin Nutr 2002; 76: 1345–1350.
7. Tai V, Leung W, Grey A. Calcium intake and bone mineral density: systematic review and meta-analysis. BMJ 2015; 351: h4183.
8. Reid IR, Bolland MJ, Grey A., Effects of vitamin D supplements on bone mineral density: a systematic review and meta-analysis. Lancet 2014; 383: 146–155.
9. Bischoff-Ferrari HA, Willett WC, Wong JB. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 2005; 293: 2257–2264.
10. Boonen S, Lips P, Bouillon R. Need for additional calcium to reduce the risk of hip fracture with vitamin D supplementation: evidence from a comparative meta-analysis of randomized controlled trials. J Clin Endocrinol Metab 2007; 92: 1415–1423.
11. Avenell A, Gillespie WJ, Gillespie LD. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis (update). Cochrane Database Syst Rev 2009; 2: CD000227.
12. Jackson RD, LaCroix AZ, Gass M. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 2006; 354: 669–683.
13. Abrahamsen B, Masud T, Avenell A. Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe. BMJ 2010; 340: b5463.
14. Avenell A, Mak JCS, O’Connell D., Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men. Cochrane Database Syst Rev 2014; 4: CD000227.
15. Hsia J, Heiss G, Ren H. Calcium/vitamin D supplementation and cardiovascular events. Circulation 2007; 115: 846–854.
16. Bolland MJ, Grey A, Avenell A. Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women’s Health Initiative limited access dataset and meta-analysis. BMJ 2011; 342: d2040.
17. Abrahamsen B, Sahota O., Do calcium plus vitamin D supplements increase cardiovascular risk? BMJ 2011; 342: d2080.
18. Rothwell PM., Subgroup analysis in randomised controlled trials: importance, indications, and interpretation. Lancet 2005; 365: 176–186.
19. Radford LT, Bolland MJ, Gamble GD. Subgroup analysis for the risk of cardiovascular disease with calcium supplements. Bonekey Rep 2013; 2: 293.
20. Lewis JR, Radavelli-Bagatini S, Rejnmark L. The effects of calcium supplementation on verified coronary heart disease hospitalization and death in postmenopausal women: a collaborative meta-analysis of randomized controlled trials. J Bone Miner Res 2014; 30: 165–175.
21. Bolland MJ, Avenell A, Baron JA. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ 2010; 341: c3691.
22. Van Hemelrijck M, Michaelsson K, Linseisen J. Calcium intake and serum concentration in relation to risk of cardiovascular death in NHANES III. PLoS One 2013; 8: e61037.
23. Xiao Q, Murphy RA, Houston DK. Dietary and supplemental calcium intake and cardiovascular disease mortality: the National Institutes of Health-AARP diet and health study. JAMA Intern Med 2013; 173: 639–646.
24. Li K, Kaaks R, Linseisen J. Associations of dietary calcium intake and calcium supplementation with myocardial infarction and stroke risk and overall cardiovascular mortality in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition study (EPIC-Heidelberg). Heart 2012; 98: 920–925.
25. Khan B, Nowson CA, Daly RM. Higher dietary calcium intakes are associated with reduced risks of fractures, cardiovascular events and mortality: a prospective cohort study of older men and women. J Bone Miner Res 2015; 30: 1758–1766.
26. Michaelsson K, Wolk A, Langenskiold S. Milk intake and risk of mortality and fractures in women and men: cohort studies. BMJ 2014; 349: g6015.
27. Asemi Z, Saneei P, Sabihi SS. Total, dietary, and supplemental calcium intake and mortality from all-causes, cardiovascular disease, and cancer: a meta-analysis of observational studies. Nutr Metab Cardiovasc Dis 2015; 25: 623–634.
28. Prentice RL, Pettinger MB, Jackson RD. Health risks and benefits from calcium and vitamin D supplementation: women’s Health Initiative clinical trial and cohort study. Osteoporos Int 2013; 24: 567–580.
29. Rejnmark L, Avenell A, Masud T. Vitamin D with calcium reduces mortality: patient level pooled analysis of 70,528 patients from eight major vitamin D trials. J Clin Endocrinol Metab 2012; 97: 1–12.
30. Bjelakovic G, Gluud LL, Nikolova D. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev 2014; 1: CD007470.
31. Bolland MJ, Grey A, Gamble GD. The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis. Lancet Diabetes Endocrinol 2014; 2: 307–320.
32. Bjelakovic G, Gluud LL, Nikolova D. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev 2011; 7: CD007470.
33. Manson JE, Bassuk SS, Lee IM. The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemp Clin Trials 2012; 33: 159–171.
34. Scragg R, Waayer D, Stewart AW. The Vitamin D Assessment (ViDA) Study: design of a randomized controlled trial of vitamin D supplementation for the prevention of cardiovascular disease, acute respiratory infection, falls and non-vertebral fractures. J Steroid Biochem Mol Biol. Epub ahead of print 10 September 2015. DOI: 10.1016/j.jsbmb.2015.09.010.
35. Neale RE, Armstrong BK, Baxter C. The D-Health Trial: a randomized trial of vitamin D for prevention of mortality and cancer. Contemp Clin Trials 2016; 48: 83–90.